{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:28:17Z","timestamp":1791599297184,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.ahj.2008.03.012","type":"journal-article","created":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T08:07:55Z","timestamp":1212653275000},"page":"348-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis"],"prefix":"10.1016","volume":"156","clinical-trial-number":[{"clinical-trial-number":"actrn012606000125527","registry":"10.18810\/anzctr"}],"author":[{"given":"Ralph A.H.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett R.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Occleshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Mark","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian A.","family":"Whalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Freidlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Doughty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey D.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2008.03.012_bib1","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1161\/CIRCULATIONAHA.104.486738","article-title":"Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies","volume":"111","author":"Freeman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.03.012_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/hrt.2005.066852","article-title":"Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both?","volume":"92","author":"Newby","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2008.03.012_bib3","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.03.012_bib4","first-page":"H1802","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ahj.2008.03.012_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.03.012_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.03.012_bib7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.03.012_bib8","series-title":"SF-36 health survey manual & interpretation guide","author":"Ware","year":"2000"},{"key":"10.1016\/j.ahj.2008.03.012_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1148\/radiology.216.2.r00au14597","article-title":"Left ventricular mass and volume: fast calculation with guide-point modeling on MR images","volume":"216","author":"Young","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.ahj.2008.03.012_bib10","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ahj.2008.03.012_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1067\/mje.2002.120202","article-title":"Recommendations for quantification of Doppler echocardiography: a report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography","volume":"15","author":"Quinones","year":"2002","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ahj.2008.03.012_bib12","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0735-1097(97)00344-6","article-title":"Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures","volume":"30","author":"Nagueh","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.03.012_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2265.1997.2361058.x","article-title":"Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment","volume":"47","author":"Hunt","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ahj.2008.03.012_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0895-7061(94)00178-E","article-title":"Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient","volume":"8","author":"Bottini","year":"1995","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ahj.2008.03.012_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1198\/000313006X90684","article-title":"Symmetrized percent change for treatment comparisons","volume":"60","author":"Berry","year":"2006","journal-title":"Am Stat"},{"key":"10.1016\/j.ahj.2008.03.012_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jacc.2007.03.062","article-title":"Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure","volume":"50","author":"Chan","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.03.012_bib17","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1172\/JCI114924","article-title":"Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy","volume":"86","author":"Schunkert","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2008.03.012_bib18","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000121426.43044.2B","article-title":"Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy","volume":"109","author":"Tsybouleva","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.03.012_bib19","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1253\/circj.70.995","article-title":"Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy","volume":"70","author":"Taniguchi","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2008.03.012_bib20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0735-1097(02)02921-2","article-title":"Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value","volume":"41","author":"Wang","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.03.012_bib21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ahj.2004.03.049","article-title":"Tissue Doppler imaging in patients with moderate to severe aortic valve stenosis: clinical usefulness and diagnostic accuracy","volume":"148","author":"Bruch","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2008.03.012_bib22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.amjcard.2003.07.012","article-title":"Effect of aortic valve replacement on C-reactive protein in nonrheumatic aortic stenosis","volume":"92","author":"Gerber","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2008.03.012_bib23","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/01.CIR.90.4.1786","article-title":"Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy","volume":"90","author":"Levy","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.03.012_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/euhj.2001.2774","article-title":"Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave; the Copenhagen City Heart Study","volume":"23","author":"Larsen","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2008.03.012_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.105.569491","article-title":"Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study","volume":"113","author":"Okin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.03.012_bib26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/hrt.2006.100164","article-title":"Longitudinal left ventricular contractile dysfunction after exercise in aortic stenosis","volume":"93","author":"Van Pelt","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2008.03.012_bib27","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.0000126825.50903.18","article-title":"Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis","volume":"109","author":"Bergler-Klein","year":"2004","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308001981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308001981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:36:48Z","timestamp":1757569008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870308001981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0002870308001981"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2008.03.012","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2008.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}